Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Ocko currently holds 1,356,524 shares of Zymergen Inc. (ZY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Ocko has been a net seller of ZY stock. They have purchased $0 and sold $90.3M worth of shares.
Matthew Ocko's most recent insider trade was on Sep 16, 2025, when they sold 22,130 shares at $51.79 per share.
Matthew Ocko serves as Executive at Zymergen Inc. (ZY). They have executed 26 insider transactions totaling $90.3M over their tenure at the company.
Matthew Ocko holds the position of Executive at Zymergen Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Matthew Ocko has shown a selling trading pattern, with $0 in total purchases and $90.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Ocko was on Sep 16, 2025, when they sold $35.4M worth of RKLB shares. This transaction involved 745,239 shares at $47.49 per share.
Matthew Ocko currently owns 1,356,524 shares of Zymergen Inc. (ZY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Ocko's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Ocko has 26 Form 4 filings on record as an insider at Zymergen Inc..
Set alerts for Matthew Ocko and 40,000+ other insiders.